Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| |
| Authors: | Tjeerd van der Veer,Marloes A. Dallinga,Johanna P. M. van der Valk,Jasper H. Kappen,Johannes C. C. M. in ’ t Veen,Menno M. van der Eerden,Gert‐ Jan Braunstahl |
| |
| Affiliation: | 1. Department of Pulmonary Medicine, Franciscus Gasthuis & Vlietland, Rotterdam The Netherlands ; 2. Department of Pulmonary Medicine, Erasmus MC, Rotterdam The Netherlands ; 3. Allergy and Clinical Immunology, Immunomodulation and Tolerance Group, Inflammation Repair and Development, Imperial College, National Heart and Lung Institute, London UK |
| |
| Abstract: | |
| |
| Keywords: | ABPA allergic bronchopulmonary aspergillosis asthma dupilumab |
|
|
